BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 33826754)

  • 21. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
    Kyrgidis A; Tzellos T; Mocellin S; Apalla Z; Lallas A; Pilati P; Stratigos A
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD010307. PubMed ID: 25978975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival impact of immediate complete lymph node dissection for Chinese acral and cutaneous melanoma with micrometastasis in sentinel nodes: a retrospective study.
    Zhong J; Zou Z; Hu T; Sun W; Wang C; Yan W; Luo Z; Liu X; Xu Y; Chen Y
    Clin Exp Med; 2023 Nov; 23(7):4003-4010. PubMed ID: 37300655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse.
    Govindarajan A; Ghazarian DM; McCready DR; Leong WL
    Ann Surg Oncol; 2007 Feb; 14(2):906-12. PubMed ID: 17136471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.
    Wong SL; Morton DL; Thompson JF; Gershenwald JE; Leong SP; Reintgen DS; Gutman H; Sabel MS; Carlson GW; McMasters KM; Tyler DS; Goydos JS; Eggermont AM; Nieweg OE; Cosimi AB; Riker AI; G Coit D
    Ann Surg Oncol; 2006 Jun; 13(6):809-16. PubMed ID: 16604476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
    Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
    J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?
    Rios-Cantu A; Lu Y; Melendez-Elizondo V; Chen M; Gutierrez-Range A; Fadaki N; Thummala S; West-Coffee C; Cleaver J; Kashani-Sabet M; Leong SPL
    Clin Exp Metastasis; 2017 Jun; 34(5):345-350. PubMed ID: 28699042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Completion Lymph Node Dissection for Sentinel Lymph Node-Positive Melanoma.
    Hieken TJ; Kane JM; Wong SL
    Ann Surg Oncol; 2019 Apr; 26(4):1028-1034. PubMed ID: 30284132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanoma sentinel lymph node biopsy and completion lymph node dissection: A regional hospital experience.
    Williams TS; Tallon B; Adams BM
    J Plast Reconstr Aesthet Surg; 2022 Feb; 75(2):730-736. PubMed ID: 34789434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma.
    Bartlett EK; Lee AY; Spanheimer PM; Bello DM; Brady MS; Ariyan CE; Coit DG
    Br J Surg; 2020 Oct; 107(11):1480-1488. PubMed ID: 32484242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin.
    Melstrom LG; Taylor E; Kuk D; Frankel TL; Panageas K; Haydu L; Sabel MS; Thompson JF; Ariyan C; Coit DG; Brady MS
    Ann Surg Oncol; 2014 Dec; 21(13):4324-9. PubMed ID: 24962937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Staging of Sentinel Lymph Nodes Identifies Melanoma Patients at Increased Risk of Nodal Recurrence.
    Kimbrough CW; Egger ME; McMasters KM; Stromberg AJ; Martin RC; Philips P; Scoggins CR
    J Am Coll Surg; 2016 Apr; 222(4):357-63. PubMed ID: 26875070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease.
    Uppal A; Stern S; Thompson JF; Foshag L; Mizzollo N; Nieweg OE; Hoekstra HJ; Roses DF; Sondak VK; Kashani-Sabet M; Coventry BJ; Cochran AJ; Fujita M; Sim-Shin M; Elashoff D; Elashoff RM; Faries MB
    Ann Surg Oncol; 2020 Jun; 27(6):1970-1977. PubMed ID: 31863416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection.
    Torphy RJ; Friedman C; Ho F; Leonard LD; Thieu D; Lewis KD; Medina TM; Robinson WA; Gonzalez RC; Stewart CL; Kounalakis N; McCarter MD; Gleisner A
    Ann Surg Oncol; 2022 Feb; 29(2):806-815. PubMed ID: 34537899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I).
    Faries MB; Thompson JF; Cochran A; Elashoff R; Glass EC; Mozzillo N; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Wang HJ; Morton DL;
    Ann Surg Oncol; 2010 Dec; 17(12):3324-9. PubMed ID: 20614193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging.
    Gjorup CA; Woodford R; Li I; Carlino MS; Ch'ng S; Chung D; Hsiao E; Lo SN; London K; Long GV; Menzies AM; Nieweg OE; Pennington TE; Rtshiladze MA; Saw RPM; Scolyer RA; Shannon KF; Spillane AJ; Stretch JR; Thompson JF; Varey AHR; van Akkooi ACJ
    Ann Surg Oncol; 2024 Mar; 31(3):1857-1864. PubMed ID: 37966706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stage IIIa Melanoma and Impact of Multiple Positive Lymph Nodes on Survival.
    Woeste MR; McMasters KM; Egger ME
    J Am Coll Surg; 2021 Apr; 232(4):517-524.e1. PubMed ID: 33316426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Zealand patients have a higher melanoma burden in sentinel nodes and completion lymphadenectomy than patients in MSLT-II.
    Williams TS; Arahill-Whitham J; Bailey TA; Hayward G; Li A; Tallon B; Wen D; Adams BM
    J Plast Reconstr Aesthet Surg; 2023 Aug; 83():98-105. PubMed ID: 37271003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy.
    Kingham TP; Panageas KS; Ariyan CE; Busam KJ; Brady MS; Coit DG
    Ann Surg Oncol; 2010 Feb; 17(2):514-20. PubMed ID: 19924486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Completion Lymph Node Dissection or Radiation Therapy for Sentinel Node Metastasis in Merkel Cell Carcinoma.
    Lee JS; Durham AB; Bichakjian CK; Harms PW; Hayman JA; McLean SA; Harms KL; Burns WR
    Ann Surg Oncol; 2019 Feb; 26(2):386-394. PubMed ID: 30556118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma.
    Oude Ophuis CM; van Akkooi AC; Rutkowski P; Powell WE; Robert C; Testori A; van Leeuwen BL; Siegel P; Eggermont AM; Verhoef C; Grünhagen DJ
    Br J Surg; 2017 May; 104(6):726-733. PubMed ID: 28218385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.